MoonLake Immunotherapeutics
MLTX
#3795
Rank
A$4.01 B
Marketcap
$63.38
Share price
0.05%
Change (1 day)
-15.03%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2024 (TTM): -A$0.22 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$86.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.23 Billion164.38%
2023 -A$86.06 Million-16.81%
2022 -A$0.11 Billion